Literature DB >> 32107424

Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants.

Raju Dash1, Ho Jin Choi1, Il Soo Moon2.   

Abstract

Recently, the critical roles played by genetic variants of TREM2 (Triggering Receptor Expressed on Myeloid cells 2) in Alzheimer's disease have been aggressively highlighted. However, few studies have focused on the deleterious roles of Nasu-Hakola disease (NHD) associated TREM2 variants. In order to get insights into the contributions made by these variants to neurodegeneration, we investigated the influences of four NHD associated TREM2 mutations (Y38C, W50C, T66M, and V126G) on loss-of-function, and followed this with in silico prediction and conventional molecular dynamics simulation. NHD mutations were predicted to be highly deleterious by eight different in silico bioinformatics tools and found to induce conformational changes by molecular dynamics simulation. As compared with the wild-type, the four variants produced substantial differences in the collective motions of loop regions, which not only promoted structural remodeling in the CDR2 (complementarity-determining region 2) loop but also in the CDR1 loop, by changing inter- and intra-loop hydrogen bonding networks. In addition, structural studies in a free energy landscape analysis showed that Y38, T66, and V126 are crucial for maintaining the structural features of CDR1 and CDR2 loops, and that mutations in these positions produced steric clashes and loss of ligand binding. These results showed the presence of mutations in the TREM2 ectodomain induced flexibility and caused structural alterations. Dynamical scenarios, as provided by the present study, may be critical to our understanding of the roles of these TREM2 mutations in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32107424      PMCID: PMC7046722          DOI: 10.1038/s41598-020-60561-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  58 in total

1.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

2.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

3.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia.

Authors:  Felix L Yeh; Yuanyuan Wang; Irene Tom; Lino C Gonzalez; Morgan Sheng
Journal:  Neuron       Date:  2016-07-20       Impact factor: 17.173

4.  TREM2 sustains microglial expansion during aging and response to demyelination.

Authors:  Pietro Luigi Poliani; Yaming Wang; Elena Fontana; Michelle L Robinette; Yoshinori Yamanishi; Susan Gilfillan; Marco Colonna
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

5.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Authors:  Yuka Atagi; Chia-Chen Liu; Meghan M Painter; Xiao-Fen Chen; Christophe Verbeeck; Honghua Zheng; Xia Li; Rosa Rademakers; Silvia S Kang; Huaxi Xu; Steven Younkin; Pritam Das; John D Fryer; Guojun Bu
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

6.  Specific lipid recognition is a general feature of CD300 and TREM molecules.

Authors:  John P Cannon; Marci O'Driscoll; Gary W Litman
Journal:  Immunogenetics       Date:  2011-07-29       Impact factor: 2.846

7.  Pattern recognition by TREM-2: binding of anionic ligands.

Authors:  Michael R Daws; Paul M Sullam; Eréne C Niemi; Thomas T Chen; Nadia K Tchao; William E Seaman
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

8.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

9.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  6 in total

1.  Osteoporosis and Dementia: Establishing a Link.

Authors:  Christine W Lary; Clifford J Rosen; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2021-09-19       Impact factor: 6.741

2.  Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.

Authors:  Raju Dash; Yeasmin Akter Munni; Sarmistha Mitra; Ho Jin Choi; Sultana Israt Jahan; Apusi Chowdhury; Tae Jung Jang; Il Soo Moon
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

3.  Computational SNP Analysis and Molecular Simulation Revealed the Most Deleterious Missense Variants in the NBD1 Domain of Human ABCA1 Transporter.

Authors:  Raju Dash; Md Chayan Ali; Md Liton Rana; Yeasmin Akter Munni; Largess Barua; Israt Jahan; Mst Fatema Haque; Md Abdul Hannan; Il Soo Moon
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

4.  Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (Piper betle L.) for Investigating the Potential Inhibition of Alpha-Amylase and Alpha-Glucosidase of Type 2 Diabetes.

Authors:  Sabbir Ahmed; Md Chayan Ali; Rumana Akter Ruma; Shafi Mahmud; Gobindo Kumar Paul; Md Abu Saleh; Mohammed Merae Alshahrani; Ahmad J Obaidullah; Sudhangshu Kumar Biswas; Md Mafizur Rahman; Md Mizanur Rahman; Md Rezuanul Islam
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

5.  N-acetyl-D-glucosamine kinase binds dynein light chain roadblock 1 and promotes protein aggregate clearance.

Authors:  Md Kamal Hossain Ripon; HyunSook Lee; Raju Dash; Ho Jin Choi; Diyah Fatimah Oktaviani; Il Soo Moon; Md Nazmul Haque
Journal:  Cell Death Dis       Date:  2020-08-14       Impact factor: 8.469

6.  Structural Consequence of Non-Synonymous Single-Nucleotide Variants in the N-Terminal Domain of LIS1.

Authors:  Ho Jin Choi; Sarmistha Mitra; Yeasmin Akter Munni; Raju Dash; Sarmin Ummey Habiba; Md Sohel; Sultana Israt Jahan; Tae Jung Jang; Il Soo Moon
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.